Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2015

Open Access 01-12-2015 | Research article

Cross-border collaboration between China and Myanmar for emergency response to imported vaccine derived poliovirus case

Authors: Hai-Bo Wang, Li-Fen Zhang, Wen-Zhou Yu, Ning Wen, Dong-Mei Yan, Jing-Jing Tang, Yong Zhang, Chun-Xiang Fan, Kathleen H Reilly, Wen-Bo Xu, Li Li, Zheng-Rong Ding, Hui-Ming Luo

Published in: BMC Infectious Diseases | Issue 1/2015

Login to get access

Abstract

Background

This report describes emergency response following an imported vaccine derived poliovirus (VDPV) case from Myanmar to Yunnan Province, China and the cross-border collaboration between China and Myanmar. Immediately after confirmation of the VDPV case, China disseminated related information to Myanmar with the assistance of the World Health Organization.

Methods

A series of epidemiological investigations were conducted, both in China and Myanmar, including retrospective searches of acute flaccid paralysis (AFP) cases, oral poliovirus vaccine (OPV) coverage assessment, and investigation of contacts and healthy children.

Results

All children <2 years of age had not been vaccinated in the village where the VDPV case had lived in the past 2 years. Moreover, most areas were not covered for routine immunization in this township due to vaccine shortages and lack of operational funds for the past 2 years.

Conclusions

Cross-border collaboration may have prevented a potential outbreak of VDPV in Myanmar. It is necessary to reinforce cross-border collaboration with neighboring countries in order to maximize the leverage of limited resources.
Literature
1.
Tracking progress towards global polio eradication, 2011 - 2012. Wkly Epidemiol Rec. 2013; 88(15):153-60
2.
Resurgence of wild poliovirus type 1 transmission and consequences of importation--21 countries, 2002-2005. MMWR Morb Mortal Wkly Rep. 2006; 55(6):145-50
3.
Wild poliovirus type 1 and type 3 importations--15 countries, Africa, 2008-2009. MMWR Morb Mortal Wkly Rep. 2009; 58(14):357-62
4.
Progress toward interruption of wild poliovirus transmission--worldwide, January 2007-April 2008. MMWR Morb Mortal Wkly Rep. 2008; 57(18):489-94
5.
Poliomyelitis in Tajikistan: first importation since Europe certified polio-free. Wkly Epidemiol Rec. 2010; 85(18):157-58.
6.
Xu J, Liu H. The challenges of malaria elimination in Yunnan Province, People’s Republic of China. Southeast Asian J Trop Med Public Health. 2012;43(4):819–24.PubMed
7.
Liang X, Zhang Y, Xu W, Wen N, Zuo S, Lee LA, et al. An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China. J Infect Dis. 2006;194(5):545–51.CrossRefPubMed
8.
National Committee for the Certification of Poliomyelitis Eradication in China. Documentation for the certification of poliomyelitis eradication. Beijing: People’s Republic of China. 2000.
9.
Progress toward poliomyelitis eradication--Myanmar, 1996-1999. MMWR Morb Mortal Wkly Rep. 1999; 48(42):967-71
10.
Importation of wild poliovirus into Qinghai Province--China, 1999. MMWR Morb Mortal Wkly Rep. 2000; 49(6):113-14
11.
From the Centers for Disease Control and Prevention. Importation of wild poliovirus into Qinghai Province--China, 1999. JAMA. 2000; 283(11):1414-15
12.
Progress toward interruption of wild poliovirus transmission--worldwide, January 2011-March 2012. MMWR Morb Mortal Wkly Rep. 2012; 61(19):353-57
13.
Wen N, Fan CX, Fu JP, Ning J, Ji YX, Luo HM, et al. Enhanced surveillance of acute flaccid paralysis following importation of wild poliovirus in Xinjiang Uygur Autonomous Region, China. BMC Infect Dis. 2014;14(1):113.CrossRefPubMedPubMedCentral
14.
Luo HM, Zhang Y, Wang XQ, Yu WZ, Wen N, Yan DM, et al. Identification and control of a poliomyelitis outbreak in Xinjiang, China. N Engl J Med. 2013;369(21):1981–90.CrossRefPubMed
15.
Progress towards interrupting wild poliovirus transmission worldwide, January 2007-April 2008. Wkly Epidemiol Rec. 2008; 83(19):170-77
16.
Wang H, Cui H, Ding Z, Ba P, Zhu S, Wen N, et al. Seroprevalence of Antipolio Antibodies among Children <15 Years of Age in Border Provinces in China. Clin Vaccine Immunol. 2013;20(7):1070–5.CrossRefPubMedPubMedCentral
17.
Shimizu H, Thorley B, Paladin FJ, Brussen KA, Stambos V, Yuen L, et al. Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol. 2004;78(24):13512–21.CrossRefPubMedPubMedCentral
18.
Burns CC, Shaw J, Jorba J, Bukbuk D, Adu F, Gumede N, et al. Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol. 2013;87(9):4907–22.CrossRefPubMedPubMedCentral
19.
Progress toward poliomyelitis eradication--Afghanistan and Pakistan, January 2003-May 2004. MMWR Morb Mortal Wkly Rep. 2004; 53(28):634-37
20.
Progress toward interruption of wild poliovirus transmission--worldwide, January 2006-May 2007. MMWR Morb Mortal Wkly Rep. 2007; 56(27):682-85
21.
22.
Metadata
Title
Cross-border collaboration between China and Myanmar for emergency response to imported vaccine derived poliovirus case
Authors
Hai-Bo Wang
Li-Fen Zhang
Wen-Zhou Yu
Ning Wen
Dong-Mei Yan
Jing-Jing Tang
Yong Zhang
Chun-Xiang Fan
Kathleen H Reilly
Wen-Bo Xu
Li Li
Zheng-Rong Ding
Hui-Ming Luo
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2015
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-015-0745-y

Other articles of this Issue 1/2015

BMC Infectious Diseases 1/2015 Go to the issue

Debate

Pneumococcal serotype evolution in Western Europe

Research article

Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance

Research article

Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom

Research article

The epidemiology of herpes zoster and its complications in Medicare cancer patients

Research article

Impact of elevated maternal HIV viral load at delivery on T-cell populations in HIV exposed uninfected infants in Mozambique

Research article

The face of Ebola: changing frequency of haemorrhage in the West African compared with Eastern-Central African outbreaks
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits